Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Devin M. Pillis"'
Autor:
Rajeswari Jayavaradhan, Devin M. Pillis, Michael Goodman, Fan Zhang, Yue Zhang, Paul R. Andreassen, Punam Malik
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-13 (2019)
Global inhibition of NHEJ factors has been one strategy to improve CRISPR-Cas9 mediated HDR. Here the authors fuse a dominant-negative mutant of 53BP1 to Cas9 to enhance HDR frequency, reduce NHEJ specifically at the Cas9 cut sites, and reduce the to
Externí odkaz:
https://doaj.org/article/af6eb1ef193d4ac7958e34f1c42a6fa1
Autor:
Sho Yoshimatsu, Junko Okahara, Junko Yohie, Yoko Igarashi, Ryusuke Nakajima, Tsukasa Sanosaka, Emi Qian, Hiroya Kobayashi, Satoru Morimoto, Noriyuki Kishi, Devin M. Pillis, Punam Malik, Toshiaki Noce, Hideyuki Okano
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fadc56fca3fe4600327494df9c189aa
https://doi.org/10.2139/ssrn.4319536
https://doi.org/10.2139/ssrn.4319536
Publikováno v:
JCI insight. 7(9)
Gene therapy involves a substantial loss of hematopoietic stem and progenitor cells (HSPC) during processing and homing. Intra-BM (i.b.m.) transplantation can reduce homing losses, but prior studies have not yielded promising results. We studied the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bc035c5f79adf343921ca159cfd34a0
https://pubmed.ncbi.nlm.nih.gov/35531956
https://pubmed.ncbi.nlm.nih.gov/35531956
Autor:
Agnès-Laurence Chenine, Lindsay Wieczorek, Eric Sanders-Buell, Maggie Wesberry, Teresa Towle, Devin M Pillis, Sebastian Molnar, Robert McLinden, Tara Edmonds, Ivan Hirsch, Robert O'Connell, Francine E McCutchan, David C Montefiori, Christina Ochsenbauer, John C Kappes, Jerome H Kim, Victoria R Polonis, Sodsai Tovanabutra
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e76104 (2013)
Standardized assays to assess vaccine and antiviral drug efficacy are critical for the development of protective HIV-1 vaccines and drugs. These immune assays will be advanced by the development of standardized viral stocks, such as HIV-1 infectious
Externí odkaz:
https://doaj.org/article/c0b36090a11d4ac489e4bbf4ec7be29c
Autor:
Eric Sanders-Buell, John C. Kappes, Sebastian Molnar, Ivan Hirsch, David C. Montefiori, Teresa Towle, Devin M. Pillis, Lindsay Wieczorek, Robert J. O'Connell, Maggie Wesberry, Jerome H. Kim, Victoria R. Polonis, Tara G. Edmonds, Francine E. McCutchan, Christina Ochsenbauer, Robert McLinden, Agnès-Laurence Chenine, Sodsai Tovanabutra
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e76104 (2013)
PLoS ONE
PLoS ONE
Standardized assays to assess vaccine and antiviral drug efficacy are critical for the development of protective HIV-1 vaccines and drugs. These immune assays will be advanced by the development of standardized viral stocks, such as HIV-1 infectious
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c17ffd2cfcd1938355e8cfd0a59a462
http://europepmc.org/articles/PMC3843658?pdf=render
http://europepmc.org/articles/PMC3843658?pdf=render
Publikováno v:
JCI Insight, Vol 7, Iss 9 (2022)
Gene therapy involves a substantial loss of hematopoietic stem and progenitor cells (HSPC) during processing and homing. Intra-BM (i.b.m.) transplantation can reduce homing losses, but prior studies have not yielded promising results. We studied the
Externí odkaz:
https://doaj.org/article/c986dceb3e8f41aea8f1149a5517ffe5